scispace - formally typeset
C

Charles L. Loprinzi

Researcher at Mayo Clinic

Publications -  579
Citations -  38967

Charles L. Loprinzi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 96, co-authored 557 publications receiving 34416 citations. Previous affiliations of Charles L. Loprinzi include McGill University & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

TL;DR: In this paper, the authors conducted a randomized, double-blind trial to determine the effect of aspirin on the incidence of colorectal adenomas, which was terminated early by an independent data and safety monitoring board when statistically significant results were reported during a planned interim analysis.
Journal ArticleDOI

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

TL;DR: Patients with high-risk resected colon cancer obtain benefit from FU-based therapy across subsets of age, sex, location, T stage, nodal status, and grade, which may improve patients' and physicians' understanding of the potential benefits of adjuvant therapy.
Journal ArticleDOI

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

TL;DR: Venlafaxine is an effective non-hormonal treatment for hot flashes, though the efficacy must be balanced against the drug's side-effects, as well as other related antidepressants for the treatment of hot flashes.